TrialAnnals of the rheumatic diseases2011

Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis.

Ayumi Okuyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.